Vnitr Lek 2015, 61(10):905-912

Systemic glucocorticoids treatment: practical view

Michal Kršek
III. interní klinika - klinika endokrinologie a metabolizmu 1. LF UK a VFN Praha, přednosta prof. MUDr. Štěpán Svačina, DrSc., MBA

Glucocorticoids are derivatives of natural human glucocorticoid cortisol. There are used for treatment of a number of diseases and disorders for more than 65 years mainly because of their immunosuppressive properties. However, their use is accompanied by various side effects that have to be considered when treating patients. The article summarizes biological effects of glucocorticoids, main indications for their use, their side effects and precautions necessary to bear in mind during treatment.

Keywords: glucocorticoids; side effects; treatment

Received: August 16, 2015; Accepted: September 25, 2015; Published: October 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kršek M. Systemic glucocorticoids treatment: practical view. Vnitr Lek. 2015;61(10):905-912.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Hench PS, Kendall EC et al. The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Proc Staff Meet Mayo Clin 1949; 24(8): 181-197. Go to original source... Go to PubMed...
    2. Exton JH. Mechanisms of hormonal regulation of hepatic glucose metabolism. Diabetes Metab Rev 1987; 3(1): 163-183. Go to original source... Go to PubMed...
    3. Fain JN. Inhibition of glucose transport in fat cells and activation of lipolysis by glucocorticoids. In: Baxter JD, Rousseau GG (eds). Glucocorticoid Hormone Action. Springer: Berlin 1979: 547-560. ISBN 978-3540089735. Go to original source...
    4. Carter-Su C, Okamoto K. Effect of glucocorticoids on hexose transport in rat adipocytes: Evidence for decreased transporters in the plasma membrane. J Biol Chem 1985; 260(20): 11091-11098. Go to original source... Go to PubMed...
    5. Clore JN, Estep H, Ross-Clunis H et al. Adrenocorticotropin and cortisol-induced changes in urinary sodium and potassium excretion in man: Effects of spironolactone and RU 486. J Clin Endocrinol Metab 1988; 67(4): 824-831. Go to original source... Go to PubMed...
    6. Freiberg JM, Kinsella J, Sacktor B. Glucocorticoids increase the Na+-H+ exchange and decrease the Na+ gradient-dependent phosphate-uptake systems in renal brush border membrane vesicles. Proc Natl Acad Sci USA 1982; 79(16): 4932-4936. Go to original source... Go to PubMed...
    7. Cronstein BN, Kimmel SC, Levin RJ et al. A mechanism for the antiinflammatory effect of corticosteroids: The glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intracellular adhesion molecule 1. Proc Natl Acad Sci USA 1992; 89(21): 9991-9995. Go to original source... Go to PubMed...
    8. Collins S, Caron MG, Lefkowitz RJ. Beta-adrenergic receptors in hamster smooth muscle cells are transcriptionally regulated by glucocorticoids. J Biol Chem 1988; 263(19): 9067-9070. Go to original source... Go to PubMed...
    9. Meikle AW, Tyler FH. Potency and duration of action of glucocorticoids. Effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function. Am J Med 1977; 63(2): 200-207. Go to original source...
    10. Harter JG. Corticosteroids: their physiologic use in allergic disease. NY State J Med 1966; 66: 827-840.
    11. Axelrod L. Glucocorticoid therapy. Medicine (Baltimore) 1976; 55(1): 39-65. Go to original source... Go to PubMed...
    12. Axelrod L. Adrenal corticosteroids. In: Miler RR, Greenblatt DJ (eds). Handbook of drug Therapy. Elsevier North-Holland: New York: 1979.
    13. Axelrod L. Glucocorticoids. In: Kelley WN, Harris ED jr, Ruddy S (eds). Textbook of Rheumatology. 4th ed. WB Saunders: Philadelphia 1993. ISBN 9780721631561.
    14. van Raalte DH, Ouwens DM, Diamant M. Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options? Eur J Clin Invest 2009; 39(2): 81-93. Go to original source... Go to PubMed...
    15. Mazziotti G, Gazzaruso C, Giustina A. Diabetes in Cushing syndrome: basic and clinical aspects. Trends Endocrinol Metab 2011; 22(12): 499-506. Go to original source... Go to PubMed...
    16. Munir A, Newell-Price J. Management of diabetes mellitus in Cushing's syndrome. Neuroendocrinology 2010; 92(Suppl 1): S82-S85. Go to original source... Go to PubMed...
    17. Mancini T, Kola B, Mantero F et al. High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines. Clin Endocrinol 2004; 61(6): 768-777. Go to original source... Go to PubMed...
    18. Albaum JM, Youn S, Levesque LE et al. Osteoporosis management among chronic glucocorticoid users: a systematic review. J Popul Ther Clin Pharmacol 2014; 21(3): e486-e504. Dostupné z WWW: <http://www.jptcp.com/pubmed.php?articleId=488>. Go to PubMed...
    19. Marek J. Terapie kortikoidy. In: Marek J (ed) et al. Farmakoterapie vnitřních nemocí. Praha: Grada 2005: 405-412. ISBN 80-247-0839-6.

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.